Drs. John Burke and Jeff Sharman discuss practice-changing presentations in CLL and lymphomas from the ASH 2018 annual meeting in San Diego.
Expert guidance on using newly approved drugs for individualized treatment of patients with acute myeloid leukemia (AML).
Expert guidance on using newly approved drugs for individualized treatment of patients with acute myeloid leukemia (AML).
Expert answers to key questions on the current treatment of Hodgkin lymphoma from a Clinical Care Options symposium in December 2018.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.